"Die Notaufnahme befindet sich in der Diako, Knuthstraße 1, Flensburg"

During the past decade, Malteser Krankenhaus St. Franziskus Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Malteser Krankenhaus St. Franziskus Hospital" #1 sponsor was "University of Ulm" with 6 trials, followed by "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials sponsored, "German CLL Study Group" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "III. Medizinische Klinik Mannheim" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Malteser Krankenhaus St. Franziskus Hospital" #1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "Jazz Pharmaceuticals" with 1 trials as a collaborator, "National Center for Tumor Diseases, Heidelberg" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Malteser Krankenhaus St. Franziskus Hospital" are "Acute Myeloid Leukemia" (7 trials), "Acute Myeloid Leukemia (AML)" (2 trials), "Myelodysplastic Syndrome With Excess Blasts-2" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials) and "Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "Malteser Krankenhaus St. Franziskus Hospital" in a lesser frequency.

Most popular intervention types in "Malteser Krankenhaus St. Franziskus Hospital" are "Drug" (11 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Cytarabine" (2 trials), "Daunorubicin" (2 trials), "Pemetrexed" (2 trials) and "cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Malteser Krankenhaus St. Franziskus Hospital" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Malteser Krankenhaus St. Franziskus Hospital". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Malteser Krankenhaus St. Franziskus Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Malteser Krankenhaus St. Franziskus Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".